p53 mutations and codon 213 polymorphism of p53 in lung cancers of former uranium miners

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 5, 1999, Pages 309-312

  Popp, Walter ^a   Vahrenholz, Carola ^a   Schuster, Hans ^b   Wiesner, Bernhard ^c   Bauer, Peter ^a   Täuscher, Frank ^b   Plogmann, Helmut ^d   Morgenroth, Konrad ^e   Konietzko, Nikolaus ^a   Norpoth, Klaus ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Medical Center of Gera   (Germany)

^c Central Clinic   (Germany)

^d Clinic for Occupational Diseases   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Codon 213 polymorphism; Lung cancer; p53; Radon; Uranium mining

Indexed keywords

URANIUM;

ARTICLE; CARCINOGENESIS; CIGARETTE SMOKING; DNA POLYMORPHISM; EXON; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; LUNG CANCER; MINING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION INJURY; THYROID CANCER;

CODON; DNA PRIMERS; EXONS; GENES, P53; HUMANS; LUNG NEOPLASMS; MALE; MINING; MUTATION; OCCUPATIONAL DISEASES; POLYMORPHISM, GENETIC; URANIUM;

EID: 0033022364     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050279     Document Type: Article

References (22)

1. Andersson M (1997) Long-term effects of internally deposited α-particle emitting radionuclides. Dan Med Bull 44:169-190
2. Bartsch H, Hollstein M, Mustonen R, Schmidt J, Spiethoff A, Wesch H, Wiethege T, Müller K-M (1995) Screening for putative radon-specific p53 mutation hotspot in German uranium miners. Lancet 346:121
3. Bhatia K, Gutierrez MI, Huppi K, Magrath IT (1992) PCR detection of a neutral CGA/CGG dimorphism in exon 6 of the human p53 gene. Nucl Acid Res 20:928
4. Carbone D, Chiba I, Mitsudomi T (1991) Polymorphism at codon 213 within the p53 gene. Oncogene 6:1691-1692
5. De Benedetti VMG, Travis LB, Welsh JA, Leeuwen FE van, Stovall M, Clarke JA, Boice JD, Bennett WP (1996) p53 mutations in lung cancer following radiation therapy for Hodgkin's disease. Cancer Epidemiol Biomark Prevent 5:93-98
6. Enderle GJ, Friedrich K (1995) East German uranium miners (Wismut) - exposure conditions and health consequences. Stem Cells 13(suppl. 1):78-89
7. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R (1991) p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci (USA) 88:5413-5417
8. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
9. Hernandez-Boussard TM, Hainaut P (1998) A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ Health Perspect 106:385-391
10. Hillebrandt S, Streffer C, Demidchik EP, Biko J, Reiners C (1997) Polymorphisms in the p53 gene in thyroid tumours and blood samples of children from areas in Belarus. Mutat Res 381:201-207
11. Hollstein M, Bartsch H, Wesch H, Kure EH, Mustonen R, Mühlbauer K-R, Spiethoff A, Wegener K, Wiethege T, Müller K-M (1997) p53 gene mutation analysis in tumors of patients exposed to α-particles. Carcinogenesis 18:511-516
12. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (1991) p53 Mutations in nonastrocytic human brain tumors. Cancer Res 51:6202-6205
13. Salgia R, Skarin AT (1998) Molecular abnormalities in lung cancer. J Clin Oncol 16:1207-1217
14. Semenza JC, Weasel LH (1997) Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ Health Perspect 105 (suppl. 1) 155-163
15. Serra A, Gaidano GL, Revello D, Guerrasio A, Ballerini P, Favera RD, Saglio G (1992) A new TaqI polymorphism in the p53 gene. Nucl Acid Res 20:928
16. Smida J, Zitzelsberger H, Kellerer AM, Lehmann L, Minkus G, Negele T, Spelsberg F, Hieber L, Demidchik EP, Lengfelder E, Bauchinger M (1997) p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history. Int J Cancer 73:802-807
17. Sram RJ, Binkova B, Dobias L, Rössner P, Topinka J, Vesela D, Vesely D, Stejskalova J, Bavorova H, Rericha V (1993a) Monitoring genotoxic exposure in uranium miners. Environ Health Perspect 99:303-305
18. Sram RJ, Dobias L, Rössner P, Vesela D, Vesely D, Rakusova R, Rericha V (1993b) Monitoring genotoxic exposure in uranium mines. Environ Health Perspect Suppl 101 (suppl. 3) 155-158
19. Taylor JA, Watson MA, Devereux TR, Michels RY, Saccomanno G, Anderson M (1994) p53 mutation hotspot in radon-associated lung cancer. Lancet 343:86-87
20. Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, Weichselbaum RR, Yandell DW (1992) Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 326:1301-1308
21. Vähäkangas KH, Samet JM, Metcalf RA, Welsh JA, Bennett WP, Lane DP, Harris CC (1992) Mutations of p53 and ras gene in radon-associated lung cancer from uranium miners. Lancet 339:576-580
22. Vogan K, Bernstein M, Leclerc J-M, Brisson L, Brossard J, Brodeur GM, Pelletier J, Gros P (1993) Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53:5269-5273